Evidence map›Paper›PMID 33057939›Full record

ArticleJournal, genetic engineering & biotechnology2020

In vivo evaluation of the toxicity, genotoxicity, histopathological, and anti-inflammatory effects of the purified bioglycerol byproduct in biodiesel industry.

Wesam Taha Basal, Aliaa Mahmoud Issa, Shehab Eldin Sayed Mohammed, Saher Abd-Elhafeez Mazen

Open access · diamondAbstract read
In one paragraph

Article in Journal, genetic engineering & biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Wesam Taha BasalDepartment of Zoology, Faculty of Science, Cairo University, Cairo, Egypt. basalw@yahoo.com.ORCID http://orcid.org/0000-0001-5293-5500
Aliaa Mahmoud IssaDepartment of Zoology, Faculty of Science, Cairo University, Cairo, Egypt.
Shehab Eldin Sayed MohammedMisr Petroleum Company Research Center, Cairo, Egypt.
Saher Abd-Elhafeez MazenEgyptian General Petroleum Corporation, Cairo, Egypt.
Cairo University · EGEgyptian Petroleum Research Institute · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBiodiesel has gained an increased popularity as a good alternative for fossil fuel because of its unusual qualities as a biodegradable, nontoxic, and renewable diesel fuel. Hence, the economic utilization of the accumulated bioglycerol byproduct became critically important for the sustainability of biodiesel industry. The purified bioglycerol might be used as a valuable industrial stock in cosmetic, medical, and food industries. However, if the purified product is going to be used in food, drug, or any industry that involves its ingestion or skin contact by human or animals, the product should be thoroughly tested on animal models.

resultsThe present study investigated the acute toxicity, anti-inflammatory, histopathological, and genotoxic effects of zeolite-purified biogylcerol on different animal models. All the previous tests proved the ability of the purification process to improve the qualities of the crude bioglycerol to a degree comparable to the pharmaceutical grade glycerol.

conclusionIn other words, it could be concluded that zeolite-purified bioglycerol can be used in different industries that involves products consumed by human or animals.

Indexed as

Acute toxicityAnti-inflammatoryBioglycerolCarrageenanGenotoxicityHistopathology

Identifiers

PMID33057939
PMCPMC7561648
OpenAlexW3093450219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.